Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial
Naoki Wada, Mitsuhiro Mizunaga, Noriyuki Abe, Kotona Miyauchi, Shin Kobayashi, Miyu Ohtani, Ryoken Tsunekawa, Masaya Nagabuchi, Shun Morishita, Teppei Ohyama, Satoshi Yamaguchi, Hiromichi Iuchi, T. Noda, Yuji Saga, Tadasu Motoya, Norihiro Kawakami, Masayuki Nishihara, Atsushi Numata, Hidehiro Κakizaki
Topics & Concepts
MirabegronMedicineOveractive bladderClinical endpointRandomized controlled trialCrossover studyInternal medicineProspective cohort studyUrologyClinical trialAdverse effectPlaceboPathologyAlternative medicineUrinary Bladder and Prostate ResearchPelvic floor disorders treatmentsBladder and Urothelial Cancer Treatments